Dusseldorf - Delayed Quote EUR
Novavax Inc (NVV1.DU)
6.10
-0.05
(-0.81%)
As of 8:10:39 AM GMT+2. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
35.2
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| BMEA Biomea Fusion, Inc. | 36 | -- | -- | -- |
| NUVL Nuvalent, Inc. | 36 | -- | -- | -- |
| NVV1.DU Novavax Inc. R | 35 | -- | -- | -- |
| JANX Janux Therapeutics, Inc. | 35 | -- | -- | -- |
| 272.SG 272.SG,0P0001LVQK,0 | 35 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 6/2025
NVV1.DU
Category Average
2 Moderate Controversy Level
None 4 Severe
2.0 NVV1.DU
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
W1H.SG Onco-Innovations Ltd
0.9750
-0.51%
W1H.MU Onco-Innovations Ltd
0.9700
+1.04%
ONCO.NE Onco-Innovations Limited
1.5000
+0.67%
UR8.F UroGen Pharma Ltd.
11.00
+74.60%
QTTB Q32 Bio Inc.
1.6800
-1.18%
PHAR Pharming Group N.V.
11.10
-3.98%
BMEA Biomea Fusion, Inc.
2.5100
-3.83%
BLRX BioLineRx Ltd.
4.7200
-10.78%
QNTM Quantum BioPharma Ltd.
20.50
+7.89%
LIMN Liminatus Pharma, Inc.
16.71
-17.75%